Metabrain Research Competitors and Similar CompaniesClear all
Metabrain Research's competitors and similar companies include Ridgeline Therapeutics, Lobesity, UCB and Livzon Pharmaceutical Group.
 Metabrain Research Metabrain Research is a company that focuses on drug discovery specializing in metabolic disorders. |  Lobesity Lobesity (also known as Lobesity Investors) is a company engaged in the clinical and commercial development of therapies to treat obesity and related disorders. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2009 | Founding Date 2012 | Founding Date 2015 | Founding Date 1928 | Founding Date 1985 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Maisons-Alfort, FR HQ | Locations West University Place, US HQ | Locations Cleveland, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 4 | Employees 5 | Employees 1 | Employees 9,052 | Employees 9,067 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.3 b | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit €7.2b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income €1.6b (FY, 2025) | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Ridgeline Therapeutics
HQ
West University Place, US
Employees
5
Ridgeline Therapeutics is a biotechnology company engaged in drug discovery.
View companyLobesity
HQ
Cleveland, US
Employees
1
Lobesity (also known as Lobesity Investors) is a company engaged in the clinical and commercial development of therapies to treat obesity and related disorders.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company